9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Atrial fibrillation (AF) patients are at high risk of developing a stroke and anticoagulant medications are generally prescribed to prevent stroke in AF population.

          Objective:

          This study aims to evaluate stroke risk factors among hospitalized patients with AF and to assess the level of adherence to medications in AF patients and their relation with stroke.

          Methods:

          This is a case-control study conducted between June 1 st, 2018 and December 31 th, 2018 among AF patients admitted to seven tertiary Lebanese hospitals. Data were collected using a standardized questionnaire. Adherence to medications was assessed using the Lebanese Medication Adherence Scale-14. Odds ratios (OR) expressed the strength of association between the independent variables and the dependent variable and were estimated using unconditional logistic regression adjusted for confounding factors. P<0.05 determined statistical significance.

          Results:

          In total, 174 cases of AF patients were included with 87 cases and 87 controls. The risk of stroke among AF significantly increased with the presence of a history of hypertension, aOR 16.04 (95%CI, 2.27-113.37; p=0.005), history of coronary heart disease/myocardial infarction, and history of obesity. Anticoagulant medication significantly decreased the risk of stroke among AF patients, aOR 0.27 (95%CI, 0.07-0.98; P=0.047). High adherence to medications was significantly associated with a reduced risk of stroke, aOR 0.04 (95%CI, 0.01-0.23; p<0.001).

          Conclusions:

          Having a history of hypertension is one of the strongest risk factors for stroke among AF patients in Lebanon. While anticoagulant medication use was associated with a reduced risk for stroke, high adherence to medications is critical for stroke prevention. Public health interventions are needed to tackle low-adherence to medication and prevent stroke among AF patients.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: not found
          • Article: not found

          Adherence to Long-Term Therapies: Evidence for Action

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

            Objective To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin. Design Retrospective, propensity matched cohort study. Setting: Optum Labs Data Warehouse, a large database including administrative claims data on privately insured and Medicare Advantage enrollees. Participants New users of dabigatran, rivaroxaban, and warfarin from 1 November 2010 to 30 September 2013. Main outcome measures Incidence rates (events/100 patient years) and propensity score matched Cox proportional hazards models were used to estimate rates of total gastrointestinal bleeds, upper gastrointestinal bleeds, and lower gastrointestinal bleeds for the novel oral anticoagulants compared with warfarin in patients with and without atrial fibrillation. Heterogeneity of treatment effect related to age was examined using a marginal effects model. Results The incidence of gastrointestinal bleeding associated with dabigatran was 2.29 (95% confidence interval 1.88 to 2.79) per 100 patient years and that associated with warfarin was 2.87 (2.41 to 3.41) per 100 patient years in patients with atrial fibrillation. In non-atrial fibrillation patients, the incidence of gastrointestinal bleeding was 4.10 (2.47 to 6.80) per 100 patient years with dabigatran and 3.71 (2.16 to 6.40) per 100 patient years with warfarin. With rivaroxaban, 2.84 (2.30 to 3.52) gastrointestinal bleeding events per 100 patient years occurred in atrial fibrillation patients (warfarin 3.06 (2.49 to 3.77)/100 patient years) and 1.66 (1.23 to 2.24) per 100 patient years in non-atrial fibrillation patients (warfarin 1.57 (1.25 to 1.99)/100 patient years). In propensity score matched models, the risk of gastrointestinal bleeding with novel oral anticoagulants was similar to that with warfarin in atrial fibrillation patients (dabigatran v warfarin, hazard ratio 0.79 (0.61 to 1.03); rivaroxaban v warfarin, 0.93 (0.69 to 1.25)) and in non-AF patients (dabigatran v warfarin, hazard ratio 1.14 (0.54 to 2.39); rivaroxaban v warfarin, 0.89 (0.60 to 1.32)). The risk of gastrointestinal bleeding increased after age 65, such that by age 76 the risk exceeded that with warfarin among atrial fibrillation patients taking dabigatran (hazard ratio 2.49 (1.61 to 3.83)) and patients with and without atrial fibrillation taking rivaroxaban (2.91 (1.65 to 4.81) and 4.58 (2.40 to 8.72), respectively). Conclusions: The risk of gastrointestinal bleeding related to novel oral anticoagulants was similar to that for warfarin. Caution should be used when prescribing novel oral anticoagulants to older people, particularly those over 75 years of age.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

              Stroke mortality is reported to be greater in blacks than in whites, but stroke incidence data for blacks and Hispanics are sparse. The aim of this study was to determine and compare stroke incidence rates among whites, blacks, and Hispanics living in the same urban community. A population-based incidence study was conducted to identify all cases of first stroke occurring in northern Manhattan, New York City, between July 1, 1993, and June 30, 1996. The population of this area was approximately 210,000 at that time, based on 1990 US Census data. Surveillance for hospitalized and nonhospitalized stroke consisted of daily screening of all admissions, discharges, and computed tomography logs at Columbia-Presbyterian Medical Center, the only hospital in the region, and review of discharge lists from outside hospitals, telephone surveys of random households, and contacts with community physicians, Visiting Nurses' Services, and community agencies. Stroke incidence increased with age and was greater in men than in women. The average annual age-adjusted stroke incidence rate at age > or =20 years, per 100,000 population, was 223 for blacks, 196 for Hispanics, and 93 for whites. Blacks had a 2.4-fold and Hispanics a twofold increase in stroke incidence compared with whites. Cerebral infarct accounted for 77 percent of all strokes, intracerebral hemorrhage for 17 percent, and subarachnoid hemorrhage for 6 percent. These data from the Northern Manhattan Stroke Study suggest that part of the reported excess stroke mortality among blacks in the United States may be a reflection of racial/ethnic differences in stroke incidence.
                Bookmark

                Author and article information

                Contributors
                Journal
                Pharm Pract (Granada)
                Pharm Pract (Granada)
                Pharmacy Practice
                Centro de Investigaciones y Publicaciones Farmaceuticas
                1885-642X
                1886-3655
                Apr-Jun 2020
                03 June 2020
                : 18
                : 2
                : 1860
                Affiliations
                MPH, PhD. Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy. Lebanese University . Beirut (Lebanon). hajj_maya@ 123456hotmail.com
                PharmD. PhD. Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy. Lebanese University . Beirut (Lebanon). rola_ajrouche@ 123456hotmail.com
                PharmD, PhD. Clinical and Epidemiological Research Laboratory, Lebanese University . Beirut (Lebanon). salam.zein@ 123456ul.edu.lb
                PharmD, PhD. Clinical and Epidemiological Research Laboratory, Lebanese University . Beirut (Lebanon). samar.rachidi@ 123456outlook.com
                PharmD, PhD. Clinical and Epidemiological Research Laboratory, Lebanese University . Beirut (Lebanon). sanaa3a@ 123456hotmail.com
                PharmD, PhD. Clinical and Epidemiological Research Laboratory, Lebanese University . Beirut (Lebanon). amalkeh@ 123456hotmail.com
                Author information
                https://orcid.org/0000-0001-9747-5675
                https://orcid.org/0000-0001-9549-2498
                https://orcid.org/0000-0003-4401-7480
                https://orcid.org/0000-0003-4781-9526
                https://orcid.org/0000-0001-9482-2483
                https://orcid.org/0000-0001-7810-3390
                Article
                pharmpract-18-1860
                10.18549/PharmPract.2020.2.1860
                7290178
                32566048
                0b25fc4f-65cf-4fc9-bee4-247e88b0d117
                Copyright: © Pharmacy Practice and the Authors

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 18 March 2020
                : 24 May 2020
                Categories
                Original Research

                atrial fibrillation,stroke,inpatients,risk factors,anticoagulants,medication adherence,hypertension,coronary disease,obesity,odds ratio,logistic models,case-control studies,lebanon

                Comments

                Comment on this article

                scite_

                Similar content266

                Cited by3

                Most referenced authors618